FHIR IG analytics

Resources that use this resource

No resources found

Resources that this resource uses

No resources found

Narrative

Note: links and images are rebased to the (stated) source

Source1

{
  "resourceType": "MedicationRequest",
  "id": "mii-exa-onko-modification-oxaliplatin-request",
  "meta": {
    "profile": [
      "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/StructureDefinition/mii-pr-onko-therapieempfehlung-medikation|2027.0.0-ballot.1"
    ]
  },
  "text": {
    "status": "generated",
    "div": "<!-- snip (see above) -->"
  },
  "status": "stopped",
  "statusReason": {
    "coding": [
      {
        "system": "http://snomed.info/sct",
        "code": "281647001",
        "display": "Adverse reaction (disorder)"
      }
    ],
    "text": "Oxaliplatin discontinued after cycle 6 due to grade 3 peripheral neuropathy (CTCAE). Patient continued with 5-FU + Leucovorin only for remaining 6 cycles."
  },
  "intent": "proposal",
  "medicationCodeableConcept": {
    "coding": [
      {
        "system": "http://fhir.de/CodeSystem/bfarm/atc",
        "code": "L01XA03",
        "display": "Oxaliplatin"
      }
    ],
    "text": "Oxaliplatin"
  },
  "subject": {
    "reference": "Patient/example-modification"
  },
  "authoredOn": "2024-03-05",
  "reasonReference": [
    {
      "reference": "Condition/mii-exa-onko-ascending-colon-cancer-diagnosis"
    }
  ],
  "note": [
    {
      "text": "Administered for cycles 1-6 only. Stopped due to cumulative neurotoxicity."
    }
  ]
}